TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8<sup>+</sup> T cell and XCR1<sup>+</sup> dendritic cell spatial co-localization

Alycia Gardner(Brigham and Women's Hospital), Brian Ruffell(Moffitt Cancer Center)
Journal for ImmunoTherapy of Cancer
January 1, 2022
10.1136/jitc-2021-003571
Cited by 49

Related Papers

Dendritic Cells and Their Role in Immunotherapy
|Frontiers in Immunology|2020|481
Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression
|Nature Materials|2020|307
Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity
|Cancer Cell|2024|52